Second, we did not systematically analyze the RNF213 p.R4810K mutation in all patients with MCAD presenting at our institutions, potentially introducing selection bias and affecting the reported incidence rate of MMD progression. This evidence concerns the gene RNF213 and medium chain acyl-CoA dehydrogenase deficiency.